Tag: Chemotherapy
Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant
Patients with stromal-predominant tumors had the youngest age at diagnosis compared with other histologic subtypes
AACR: Cadonilimab Plus Chemo Beneficial for Gastric Adenocarcinoma
Improved overall survival, progression-free survival seen, including among patients with low PD-L1 expression
Simple Risk Score Predicts Severe Cisplatin-Linked Acute Kidney Injury
Simple risk score, including nine covariates, predicted risk for CP-AKI in monotonic manner in derivation, validation cohorts
Neoadjuvant Chemo Adds Significant Treatment Benefit in Penile Cancer
In a recent study, median overall survival with neoadjuvant chemotherapy, lymphadenectomy was 37.0 months
Treatment Modification Aids Chemo Tolerability in Seniors With Advanced Cancer
Primary treatment modifications tied to lower risk for toxic effects and functional decline
Tislelizumab Plus Chemotherapy Beneficial for Resectable NSCLC
Significant benefit seen for neoadjuvant tislelizumab plus chemotherapy with adjuvant tislelizumab
Pegargiminase + Chemo Increases Survival Rate in Nonepithelioid Pleural Mesothelioma
Improved median overall survival and progression-free survival seen for pegargiminase-based chemotherapy
Fruquintinib + Paclitaxel Aids Advanced Gastric/Gastroesophageal Junction Cancer
Improvement seen in progression-free survival among patients who had disease progression on first-line chemotherapy
Race Can Affect Breast Cancer Test for Predicting Chemo Benefit
21-gene recurrence score may underestimate benefit of chemotherapy for young non-Hispanic Black women with ER-positive, axillary node-negative breast cancer
ctDNA-Based Detection of Residual Disease Prognostic for Resected CRC
ctDNA-based detection of molecular residual disease in response to adjuvant chemotherapy prognostic of outcomes
